AI Medical Intelligence
MA Salary vs AI Scribe Cost: 2027 EBITDA Analysis
Compare MA payroll cost to AI scribe pricing and model G2211-driven EBITDA impact for your practice's 2027 budget cycle.
Medical Assistant Salary vs AI Scribe Cost: 2027 Practice EBITDA Analysis
Merry AI · Thoughtfully curated clinical briefs.
Clinically reviewed by Dr. Marcus Vance, MD (Medical Informatics Advisor) · Coding review by Kaif R. (Clinical Informatics Specialist) · Sources: CY 2026 CMS PFS, NCCI Policy Manual.
An AI scribe costs about 1.3% of one medical assistant. Merry AI Pro costs $648 per year ($54 per month, billed annually), and a medical assistant (MA) costs about $48,000 fully loaded. The EBITDA case does not come from cutting MA headcount. It comes from capturing documentation-dependent revenue, mainly CPT G2211, which recovers $15,600+ per provider each year. For a Practice Administrator or CMO, a $648 subscription that supports $15,600 in collections is a margin decision, not a staffing decision.
An AI scribe costs 1.3% of one fully loaded medical assistant
The fully loaded MA denominator is $48,000. That figure includes base wages near the national median, employer payroll taxes, health benefits, paid time off, and training overhead. Merry AI Pro costs $648 per year, or 1.35% of that figure ($648 ÷ $48,000), which this brief rounds to 1.3%. Even if a practice's local MA cost rises to $55,000, the scribe stays under 1.2% of that labor line.
This ratio matters because administrators often frame AI scribes as a replacement for staff. That framing is clinically and operationally wrong. MAs room patients, take vitals, collect specimens, give injections, and run outreach. An ambient scribe does none of those tasks. The scribe handles what MAs and physicians both lose hours to: note construction, problem-list reconciliation, and assessment-and-plan documentation that supports billing.
Benchmark: $648 scribe versus $48,000 MA equals a 1.3% labor-cost ratio.
The EBITDA model treats AI scribes as margin expansion, not headcount cuts
EBITDA improves through three levers: recovered coding revenue, labor capacity sent to billable work, and lower clinician burnout turnover. The table below models one full-time primary care or cardiology-adjacent provider with a typical Medicare panel. It isolates the first lever and treats the other two as upside.
| Per-Provider Line Item | Annual Value | Basis |
|---|---|---|
| Fully loaded MA cost (2026) | $48,000 | Wages, taxes, benefits, PTO, training |
| Fully loaded MA cost (2027 projection) | $49,680 | 3.5% wage growth planning assumption |
| Merry AI Pro subscription | $648 | $54/mo billed annually |
| Scribe cost as % of MA labor | 1.3% | $648 ÷ $48,000 |
| Recovered G2211 revenue | $15,600+ | ~975 eligible visits × ~$16 |
| Net incremental EBITDA | $14,952 | $15,600 minus $648 |
| Return multiple | ~24x | $15,600 ÷ $648 |
| Payback period | ~15 days | $648 ÷ ($15,600 ÷ 365) |
At five providers, the practice adds about $74,760 in annual EBITDA from G2211 capture alone. For a practice collecting $3.0 million, that is roughly 2.5 margin points. At an illustrative 8x EBITDA multiple, which is common in physician practice transactions, the same gain adds about $598,000 in enterprise value. Use your own multiple; the arithmetic holds at any valuation.
CPT G2211 capture adds $15,600 per provider when documentation proves longitudinal care
G2211 is the visit complexity add-on code that Medicare pays with office and outpatient E/M visits (99202 to 99215). It applies when the billing practitioner is the continuing focal point for all needed services, or gives ongoing care for a single serious or complex condition. CY 2026 national non-facility payment is roughly $16 per claim under the CY 2026 conversion factor of $33.4009.
Most practices under-capture G2211 because notes do not show the longitudinal relationship. A clinician who manages heart failure and diabetes across years may write a note that reads like an episodic visit. A structured scribe output that names each chronic condition, its status, and the continuing plan gives coders a defensible basis. The CPT G2211 Complexity Capture Architecture explains how Merry AI surfaces these documentation elements for clinician review.
NCCI and CMS billing rules still apply. G2211 is not payable when the E/M visit is reported with modifier 25. The exception is when the same-day service is an Annual Wellness Visit, vaccine administration, or a Medicare Part B preventive service. Revenue cycle teams should configure claim scrubbers to flag modifier 25 conflicts before submission.
Rule: G2211 requires documented longitudinal care, not just a chronic diagnosis code.
Moderate MDM for I50.22 and E11.9 requires two chronic illnesses plus prescription management
Under AMA E/M guidelines, CPT 99214 requires moderate medical decision making (MDM). The visit must meet two of three elements: problems, data, and risk. A patient with I50.22 (ICD-10-CM), chronic systolic congestive heart failure, and E11.9 (ICD-10-CM), type 2 diabetes mellitus without complications, meets the moderate problem element through two or more stable chronic illnesses. Prescription drug management meets the moderate risk element.
| Clinical Indicator | ICD-10-CM | MDM Threshold | Target CPT | G2211 Eligible | Audit Defense |
|---|---|---|---|---|---|
| Single stable chronic illness, OTC guidance only | E11.9 | Low (1 stable chronic illness; low risk) | 99213 | Yes, if longitudinal relationship documented | Assessment names status ("A1c at goal") and continuing plan |
| Two stable chronic illnesses with prescription management | I50.22 + E11.9 | Moderate (2+ stable chronic illnesses; Rx management) | 99214 | Yes | Each problem listed with status, medication decision, and follow-up interval |
| Chronic HF with mild exacerbation, diuretic adjustment | I50.22 | Moderate (chronic illness with exacerbation; Rx management) | 99214 | Yes | Document weight change, edema exam, and dose rationale |
| Severe HF exacerbation, hospitalization decision | I50.23 or I50.22 progressing | High (severe exacerbation; decision regarding hospitalization) | 99215 | Yes, unless billed with modifier 25 for non-preventive service | Record admission discussion, alternatives considered, and patient preference |
| Same-day AWV plus problem-oriented E/M | E11.9 + I50.22 | Moderate on separate E/M | G0439 + 99214-25 | Yes (AWV exception to modifier 25 bar) | Separate note section for problem-oriented work; NCCI-compliant modifier use |
The audit defense always lives in the assessment and plan. Auditors applying NCCI Policy Manual principles expect each billed problem to show a status, a decision, and a plan. An AI-generated note that lists diagnoses without clinical reasoning fails that test. Clinicians must review and attest to the final note before signing.
Medical assistants should shift from charting to revenue-generating care coordination
If documentation support absorbs 20% of MA hours, that is $9,600 of labor capacity per MA each year (20% × $48,000). Once an ambient scribe takes over note drafting, the practice can redirect those hours to services that generate or protect revenue. Headcount stays the same.
- Chronic care management (CPT 99490): clinical staff time spent coordinating care for patients with two or more chronic conditions, such as I50.22 and E11.9.
- Care-gap closure for quality programs: retinal exam scheduling, A1c recall, and statin adherence outreach that affect MIPS and value-based contract scores.
- Prior authorization preparation: assembling clinical documentation that reduces denials and rework.
- Pre-visit planning: reconciling medications and outside records so MDM data elements are already in the chart.
This reallocation also protects retention. MA turnover is a hidden EBITDA drain because recruiting, onboarding, and lost productivity can cost a practice thousands of dollars per departure. Clinical staff who spend more time on patient-facing coordination and less on clerical rework report higher role satisfaction.
Keep MA headcount; redirect documentation hours to billable chronic care management.
State AI statutes require clinician attestation before scribe output enters the record
Compliance costs belong in the EBITDA model because a single consent or disclosure failure can erase a year of recovered G2211 revenue. Laws that affect AI scribe deployment include:
- California Penal Code 632: requires all-party consent before recording a confidential conversation.
- California AB 3030: requires disclaimers on generative AI patient communications that a licensed clinician has not reviewed.
- California SB 1120: requires a licensed physician, not an algorithm, to make medical necessity determinations in utilization review.
- Texas SB 1188: adds practitioner disclosure duties when AI is used in care.
Practice Administrators should maintain a consent workflow, a documented clinician review step, and a state-by-state policy register. The State AI Scribe Rules & Statutory Compliance Hub tracks these requirements by jurisdiction. Use it to build intake scripts and attestation language before go-live.
Browser overlay deployment avoids integration fees that erode EBITDA gains
Integration cost is the variable that most often breaks AI scribe ROI models. Deep API integrations can require vendor fees, interface engine licensing, and IT project hours. Those costs can exceed the subscription price many times over. A browser overlay works on top of the existing EHR session, so deployment does not wait for an interface build.
The overlay approach keeps the $648 figure close to the true total cost of ownership. Data flow, security boundaries, and FHIR interoperability considerations are covered in EHR Browser Overlay Architecture. Review that analysis with your compliance officer and IT lead before procurement.
2027 budgets should model 3.5% MA wage growth against fixed scribe subscriptions
For 2027 planning, assume continued wage pressure on clinical support roles. At 3.5% annual growth, the $48,000 fully loaded MA becomes about $49,680. The Merry AI Pro annual rate stays fixed for the subscription term, so the scribe-to-labor ratio falls slightly, to about 1.3% or below. This is a planning assumption, not a wage forecast. Replace it with your regional compensation data.
CMOs should also stress-test the G2211 assumption. Payment rates change with each annual Physician Fee Schedule. If the conversion factor or G2211 valuation drops 10%, recovered revenue falls to about $14,040 per provider. That still returns more than 20x the subscription cost. The investment case does not depend on favorable rulemaking.
- Baseline current G2211 capture: pull 90 days of Medicare E/M claims and calculate the attachment rate.
- Identify eligible longitudinal panels: filter for patients with chronic conditions such as I50.22 and E11.9 seen by the same practitioner.
- Pilot with two providers: measure attachment rate, MDM level distribution, and denial rate over 60 days.
- Reallocate MA hours deliberately: assign recovered capacity to chronic care management or care-gap work, and track the output.
- Report EBITDA impact quarterly: net recovered revenue minus subscription cost, per provider.
Even with 10% rate cuts, G2211 capture returns over 20x subscription cost.
Frequently asked questions about medical assistant salary vs AI scribe cost
How much does an AI scribe cost compared to a medical assistant salary?
Merry AI Pro costs $648 per year ($54 per month billed annually), which equals 1.3% of a $48,000 fully loaded medical assistant. The scribe does not replace rooming, vitals, or injections; it removes documentation burden so clinical staff time shifts toward billable care coordination.
Should a practice replace medical assistants with an AI scribe?
No. Medical assistants perform hands-on tasks an AI scribe cannot: rooming, vitals, specimen collection, injections, and patient outreach. The stronger EBITDA play keeps headcount stable, moves documentation to the scribe, and redirects recovered MA hours toward chronic care management, care-gap closure, and prior authorization work that protects revenue.
How does CPT G2211 affect AI scribe ROI?
G2211 pays roughly $16 per eligible Medicare office visit when the clinician serves as the continuing focal point for a serious or complex condition. Capturing about 975 eligible visits annually yields $15,600+ per provider, a 24x return on a $648 Merry AI Pro subscription.
What documentation defends G2211 and moderate MDM in an audit?
Auditors look for an assessment that names each chronic condition, its status, and the plan, such as I50.22 with beta-blocker management and E11.9 with metformin continuation. G2211 additionally needs evidence of an ongoing longitudinal relationship, and CMS bars it with modifier 25 except for specified preventive services.
Do state laws restrict AI scribe use in 2026?
Yes. California requires all-party consent to record conversations and AB 3030 disclaimers on unreviewed generative AI patient communications, while SB 1120 bars health plans from denying care through algorithms alone. Texas SB 1188 adds AI disclosure duties. Clinician review and attestation before signing remains the universal safeguard.